Syneos Health Communications Bolsters Value, Access and Public Affairs Offerings with Key Senior Hires
24 February 2021 - 1:51AM
Syneos Health Communications – the portfolio of Syneos Health®
agencies designed to deliver insights-driven integrated
communications spanning advertising, public relations, patient
advocacy, medical communications, managed markets, omnichannel,
digital, naming and branding – has hired five senior specialists to
deepen its leading market access and external affairs offerings.
Senior experts from the life sciences, federal government and
public affairs sectors will offer clients deep acumen, innovation
and evidence-based solutions to advance receptivity and access for
established brands and emerging therapies.
“Our entire model is about acceleration, and one of the biggest
factors impacting time to market and brand success is market access
strategy,” said Tim Pantello, President of Syneos Health
Communications. “This influx of senior talent enables us to deploy
even deeper expertise against our customers’ challenges in modern,
sophisticated communications offerings including value, pricing and
public affairs.”
Talent joining the organization spans the globe including
Mark Sudwell, Head of Value, Access and Reputation
Communications in Europe. Sudwell has more than 20 years
of experience as a corporate affairs communications leader and a
strong track record of delivering integrated campaigns that
optimize access to new therapies and communicate product and
corporate value. A former Communications Director for Lilly’s
Europe, Australia and Canada operations, Sudwell is based out of
London and reports to Nicky Walsby, Managing Director of Syneos
Health Public Relations within Europe.
Top talent joining the Syneos Health Reputation & Risk
Management Group, led by Meg Alexander, includes four strategic
hires dedicated to advancing biopharmaceutical reputation and
valuation, maximizing therapeutic access, navigating value
frameworks and fostering stakeholders’ perceptions of drug value.
New colleagues include:
Leigh Ann Bruhn, Value and Market
Access Lead, joins with more than 20 years of expertise in
value-based healthcare, market access, pricing, and reputation and
risk management having held senior roles at Pfizer, Abbott
Laboratories and Avalere Health.
Katie Conover, Senior Public
Affairs Strategist, a former FDA Assistant
Commissioner, brings more than fifteen years of experience driving
innovative media relations and advocacy campaigns to help
biopharmaceutical and payer clients build brand
reputation. Her expertise includes proactive media engagement,
crisis management and stakeholder outreach programs for companies
including Janssen, Merck, Anthem and Medtronic.
Laura Keehner Rigas, Senior Reputation Strategist,
Public Affairs and Value Access, brings a 20 year
track record of communications and public affairs successfully
managing large teams and providing strategic counsel to C-suite
level leadership in state and federal government and non-profits.
She joins Syneos Health from the Office of the Secretary at
the U.S. Department of Health and Human Services, and previously
served in senior roles at the U.S. Department of Homeland Security
and the U.S. Department of Justice.
Aneeb Sharif, Global Value and
Access Strategist, Risk and Reputation
Management, has a long tenure working with global
biopharma and life science companies including Janssen, Novartis,
and Lilly on the intersection between public affairs and value and
access. He was previously Vice President of Health at Edelman.
These new hires complement the existing depth of talent at
Syneos Health Communications who hail from prior experience in
Congress, the FDA, provider organizations, commercial payers,
financial institutions, the law and public health. They are on
executives’ speed-dials for needs at the intersection of policy and
communications, including matters surrounding the affordability of
medicines, compassionate use, safety, risk mitigation, shifting
policy landscapes and barriers to access.
Agencies within the Syneos Health Communications portfolio
specialize in payer communications and access marketing, connecting
insights, data and trends to motivate behavior. They also have
access to cross-functional Value and Access expertise across the
clinical to commercial product development spectrum.
Syneos Health Communications agencies work in scalable,
purpose-built teams that partner across disciplines and geographies
to accelerate brand performance. The portfolio includes GSW, GSW
Managed Markets, Chandler Chicco Agency, Biosector 2, Chamberlain
Healthcare Communications, Managed Markets Communications, Navicor,
Cadent Medical Communications and Addison Whitney, among
others.
About Syneos HealthSyneos
Health® (Nasdaq:SYNH) is the only fully integrated
biopharmaceutical solutions organization. The Company, including a
Contract Research Organization (CRO) and Contract Commercial
Organization (CCO), is purpose-built to accelerate customer
performance to address modern market realities. We bring together
approximately 25,000 clinical and commercial minds with the ability
to support customers in more than 110 countries. Together we share
insights, use the latest technologies and apply advanced business
practices to speed our customers’ delivery of important therapies
to patients. To learn more about how we are Shortening the
distance from lab to life®, visit syneoshealth.com or
subscribe to our podcast.
Investor Relations Contact:
|
Press/Media Contact: |
Ronnie Speight |
Gary Gatyas |
Senior Vice President, Investor Relations
|
Executive Director, External Communications |
+1 919 745 2745
|
+1 908 763 3428 |
Investor.Relations@syneoshealth.com |
gary.gatyas@syneoshealth.com |
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Syneos Health (NASDAQ:SYNH)
Historical Stock Chart
From Jul 2023 to Jul 2024